Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $933.39 | 42 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $457.36 | 28 | $0 (2019) |
| ACADIA Pharmaceuticals Inc | $156.67 | 2 | $0 (2018) |
| Madrigal Pharmaceuticals | $150.00 | 1 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $36.30 | 3 | $0 (2017) |
| PFIZER INC. | $29.15 | 2 | $0 (2018) |
| Amgen Inc. | $23.37 | 1 | $0 (2017) |
| Astellas Pharma US Inc | $18.77 | 1 | $0 (2017) |
| Purdue Pharma L.P. | $17.39 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $17.25 | 1 | $0 (2019) |
| AbbVie, Inc. | $14.10 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $150.00 | 1 | Madrigal Pharmaceuticals ($150.00) |
| 2019 | $108.31 | 7 | Janssen Pharmaceuticals, Inc ($91.06) |
| 2018 | $219.28 | 15 | Janssen Pharmaceuticals, Inc ($131.01) |
| 2017 | $455.80 | 19 | Janssen Pharmaceuticals, Inc ($235.29) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/08/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: LIVER DISEASE | ||||||
| 09/12/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/28/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.25 | General |
| Category: Cardiovascular | ||||||
| 05/23/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/22/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/11/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/12/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/11/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/18/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/12/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $2.81 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/24/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/23/2018 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $6.63 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/16/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/02/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/11/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/09/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $1.18 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/08/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/03/2018 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $62.13 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 04/27/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 04/06/2018 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $3.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/15/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $5.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/22/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $4.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/21/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/27/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $9.74 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 540 | 804 | $105,387 | $37,713 |
| 2022 | 10 | 547 | 871 | $105,948 | $39,424 |
| 2021 | 7 | 534 | 858 | $110,905 | $59,211 |
| 2020 | 11 | 596 | 914 | $106,089 | $51,591 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 87 | 96 | $20,640 | $9,363 | 45.4% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 100 | 280 | $21,000 | $7,807 | 37.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 124 | 169 | $20,618 | $7,742 | 37.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 86 | $15,480 | $4,212 | 27.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 86 | 86 | $15,996 | $4,077 | 25.5% |
| 99304 | Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Office | 2023 | 30 | 43 | $7,568 | $2,673 | 35.3% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 25 | 29 | $3,335 | $1,674 | 50.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 15 | $750.00 | $164.64 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 156 | 250 | $30,500 | $11,039 | 36.2% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Office | 2022 | 101 | 313 | $23,475 | $9,599 | 40.9% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Office | 2022 | 86 | 91 | $19,565 | $9,126 | 46.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 97 | 97 | $18,042 | $4,598 | 25.5% |
| 99304 | Initial nursing facility visit per day, typically 25 minutes | Office | 2022 | 27 | 36 | $6,336 | $2,439 | 38.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 28 | $5,040 | $1,223 | 24.3% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 13 | 14 | $1,610 | $724.09 | 45.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 17 | 17 | $680.00 | $522.85 | 76.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 14 | 14 | $700.00 | $153.86 | 22.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 11 | 11 | $0.11 | $0.11 | 100.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 162 | 285 | $34,770 | $18,807 | 54.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 104 | 104 | $19,344 | $14,346 | 74.2% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Office | 2021 | 125 | 129 | $27,735 | $13,318 | 48.0% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Office | 2021 | 90 | 274 | $20,550 | $9,131 | 44.4% |
| 99304 | Initial nursing facility visit, typically 25 minutes per day | Office | 2021 | 26 | 31 | $5,456 | $2,286 | 41.9% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 15 | 22 | $2,530 | $1,094 | 43.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 12 | 13 | $520.00 | $230.29 | 44.3% |
About Dr. Howard Perrone, M.D
Dr. Howard Perrone, M.D is a Internal Medicine healthcare provider based in Bristol, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1134120157.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Howard Perrone, M.D has received a total of $933.39 in payments from pharmaceutical and medical device companies, with $150.00 received in 2024. These payments were reported across 42 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($933.39).
As a Medicare-enrolled provider, Perrone has provided services to 2,217 Medicare beneficiaries, totaling 3,447 services with total Medicare billing of $187,939. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Bristol, RI
- Active Since 08/02/2005
- Last Updated 10/21/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1134120157
Products in Payments
- XARELTO (Drug) $357.35
- NUPLAZID (Drug) $156.67
- REZDIFFRA (Drug) $150.00
- INVOKANA (Drug) $100.01
- ZOSTAVAX (Biological) $24.78
- Corlanor (Drug) $23.37
- Myrbetriq (Drug) $18.77
- OXYCONTIN (Drug) $17.39
- ELIQUIS (Drug) $17.25
- PREVNAR - 13 (Biological) $16.04
- Synthroid (Drug) $14.10
- CHANTIX (Drug) $13.11
- TRELEGY ELLIPTA (Drug) $13.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bristol
Dr. Bernard Grunstra, Md, MD
Internal Medicine — Payments: $36,895
Charles Villoch, Md, MD
Internal Medicine — Payments: $25,124
Dr. Joseph Foley, M.d, M.D
Internal Medicine — Payments: $21,160
Dr. Nathan Gargus, M.d, M.D
Internal Medicine — Payments: $17,677
Rick Whiles, Md, MD
Internal Medicine — Payments: $17,415
Dr. Donald Quinn, Md, MD
Internal Medicine — Payments: $17,216